Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Caliway Biopharmaceuticals Co., Ltd.

Clinical trials sponsored by Caliway Biopharmaceuticals Co., Ltd., explained in plain language.

Caliway Biopharmaceuticals Co., Ltd. 6919 TWSE

A Taiwan-based biopharmaceutical company developing treatments for inflammatory and fibrotic diseases.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet recruiting 4 Not yet finished but already full! 1 Completed 2

New injection aims to melt belly fat without surgery

Disease control Recruiting now

This phase 2b trial tests an injection called CBL-514 to see if it can safely reduce abdominal fat. About 250 adults with moderate to high belly fat will receive either the drug or a placebo. The main goal is to measure fat reduction using MRI scans over time.

Phase: PHASE2 • Sponsor: Caliway Biopharmaceuticals Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 13:02 UTC